M. Zöller, Tetraspanins: push and pull in suppressing and promoting metastasis, Nature Reviews Cancer, vol.25, issue.1, pp.40-55, 2009.
DOI : 10.1016/j.tcb.2006.03.003

B. Zimmerman, B. Kelly, B. Mcmillan, T. Seegar, R. Dror et al., Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket, Cell, vol.167, issue.4, 2016.
DOI : 10.1016/j.cell.2016.09.056

S. Charrin, S. Jouannet, C. Boucheix, and E. Rubinstein, Tetraspanins at a glance, Journal of Cell Science, vol.127, issue.17, pp.3641-3649, 2014.
DOI : 10.1242/jcs.154906

Z. Wang, V. Au, A. Schnölzer, M. Hackert, T. Zöller et al., CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells, Oncotarget, vol.7, issue.34, pp.55409-55436, 2016.
DOI : 10.18632/oncotarget.10580

M. Hemler, Tetraspanin proteins promote multiple cancer stages, Nature Reviews Cancer, vol.178, issue.1, pp.49-60, 2014.
DOI : 10.4049/jimmunol.178.1.154

C. De-winde, S. Veenbergen, K. Young, Z. Xu-monette, X. Wang et al., Tetraspanin CD37 protects against the development of B cell lymphoma, Journal of Clinical Investigation, vol.126, issue.2, pp.653-66, 1172.
DOI : 10.1172/JCI81041DS1

M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson et al., Towards a knowledge-based Human Protein Atlas, Nature Biotechnology, vol.9, issue.12, pp.1248-50, 1038.
DOI : 10.1038/msb.2009.93

Z. Zhou, Y. Ran, H. Hu, J. Pan, Z. Li et al., TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression, Clinical & Experimental Metastasis, vol.579, issue.25, pp.537-585, 2008.
DOI : 10.1016/j.febslet.2005.09.024

H. Zhu, Y. Wu, W. Zheng, and S. Lu, CO-029 is overexpressed in gastric cancer and mediates the effects of EGF on gastric cancer cell proliferation and invasion, International Journal of Molecular Medicine, vol.35, issue.3, pp.798-802, 2015.
DOI : 10.3892/ijmm.2015.2069

C. Greco, M. Bralet, N. Ailane, A. Dubart-kupperschmitt, E. Rubinstein et al., E-Cadherin/p120-Catenin and Tetraspanin Co-029 Cooperate for Cell Motility Control in Human Colon Carcinoma, Cancer Research, vol.70, issue.19, pp.7674-83, 2010.
DOI : 10.1158/0008-5472.CAN-09-4482

K. Kanetaka, M. Sakamoto, Y. Yamamoto, S. Yamasaki, F. Lanza et al., Overexpression of tetraspanin CO-029 in hepatocellular carcinoma, Journal of Hepatology, vol.35, issue.5, pp.637-679, 2001.
DOI : 10.1016/S0168-8278(01)00183-0

S. Gesierich, C. Paret, D. Hildebrand, J. Weitz, K. Zgraggen et al., Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility, Clinical Cancer Research, vol.11, issue.8, pp.2840-52, 2005.
DOI : 10.1158/1078-0432.CCR-04-1935

C. Park, T. Kim, H. Kim, Y. Kim, M. Jeoung et al., Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis, Oncogene, vol.11, issue.34, 2016.
DOI : 10.4049/jimmunol.1103803

O. Berthier-vergnes, M. Kharbili, A. De-la-fouchardière, T. Pointecouteau, P. Verrando et al., Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion, British Journal of Cancer, vol.104, issue.1, pp.155-65, 2011.
DOI : 10.1038/nrc2543
URL : https://hal.archives-ouvertes.fr/hal-00709831

C. Claas, S. Seiter, A. Claas, L. Savelyeva, M. Schwab et al., Association Between the Rat Homologue of CO-029, a Metastasis-associated Tetraspanin Molecule and Consumption Coagulopathy, The Journal of Cell Biology, vol.28, issue.1, pp.267-80, 1998.
DOI : 10.1038/bjc.1978.9

M. Herlevsen, D. Schmidt, K. Miyazaki, and M. Zöller, The association of the tetraspanin D6.1A with the ??6??4 integrin supports cell motility and liver metastasis formation, Journal of Cell Science, vol.116, issue.21, pp.4373-90, 2003.
DOI : 10.1242/jcs.00760

S. Kuhn, M. Koch, T. Nübel, M. Ladwein, D. Antolovic et al., A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression, Molecular Cancer Research, vol.5, issue.6, pp.553-67, 2007.
DOI : 10.1158/1541-7786.MCR-06-0384

Q. Guo, B. Xia, F. Zhang, M. Richardson, M. Li et al., Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cellcell adhesions, PloS One, vol.7, 2012.

N. Ailane, C. Greco, Y. Zhu, M. Sala-valdã©s, M. Billard et al., Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model, Frontiers in Physiology, vol.81, p.2014, 2016.
DOI : 10.1073/pnas.81.11.3506

M. Rodia, G. Ugolini, G. Mattei, I. Montroni, D. Zattoni et al., Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection, Oncotarget, vol.7, issue.21, pp.30295-306, 2016.
DOI : 10.18632/oncotarget.8108

D. Prete, M. Giampieri, R. Faloppi, L. Bianconi, M. Bittoni et al., Panitumumab for the treatment of metastatic colorectal cancer: a review, Immunotherapy, vol.17, issue.1, pp.721-759, 2015.
DOI : 10.2165/11205090-000000000-00000

Y. Ohhara, N. Fukuda, S. Takeuchi, R. Honma, Y. Shimizu et al., Role of targeted therapy in metastatic colorectal cancer, World Journal of Gastrointestinal Oncology, vol.8, issue.9, pp.642-55, 2016.
DOI : 10.4251/wjgo.v8.i9.642

J. Tabernero, S. Chawla, H. Kindler, K. Reckamp, E. Chiorean et al., Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab, Targeted Oncology, vol.13, issue.20, pp.65-76, 2015.
DOI : 10.1158/1078-0432.CCR-07-0950

A. Repetto-llamazares, N. Abbas, Ø. Bruland, J. Dahle, and R. Larsen, Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors, Anticancer Res, vol.34, pp.3263-3272, 2014.

S. Ferrero, A. Pastore, C. Scholz, R. Forstpointner, A. Pezzutto et al., Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results www.impactjournals.com/oncotarget of a European MCL Network Phase II Trial, Leukemia, vol.30, pp.984-991, 2016.

A. Repetto-llamazares, R. Larsen, S. Patzke, K. Fleten, D. Didierlaurent et al., Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma, PLOS ONE, vol.54, issue.6, 2015.
DOI : 10.1371/journal.pone.0128816.s001

V. Vassileva, V. Rajkumar, M. Mazzantini, M. Robson, A. Badar et al., Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer, Journal of Nuclear Medicine, vol.56, issue.8, pp.1239-1284, 2015.
DOI : 10.2967/jnumed.115.157362

Y. Guo, J. Parry, R. Laforest, B. Rogers, and C. Anderson, The Role of p53 in Combination Radioimmunotherapy with 64Cu-DOTA-Cetuximab and Cisplatin in a Mouse Model of Colorectal Cancer, Journal of Nuclear Medicine, vol.54, issue.9, pp.1621-1630, 2013.
DOI : 10.2967/jnumed.112.118539

T. Lindmo, E. Boven, F. Cuttitta, J. Fedorko, and P. Bunn, Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess, Journal of Immunological Methods, vol.72, issue.1, pp.77-89, 1984.
DOI : 10.1016/0022-1759(84)90435-6

L. Rask, L. Klarkeskog, L. Ostberg, and P. Peterson, Isolation and properties of a murine spleen cell Fc receptor, Nature, vol.71, issue.5523, pp.231-234, 1975.
DOI : 10.1007/BF01564048

C. Klijn, S. Durinck, E. Stawiski, P. Haverty, Z. Jiang et al., A comprehensive transcriptional portrait of human cancer cell lines, Nature Biotechnology, vol.88, issue.3, pp.306-318, 2015.
DOI : 10.1016/j.ajhg.2011.03.004

J. Fang, H. Nakamura, and H. Maeda, The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect, Advanced Drug Delivery Reviews, vol.63, issue.3, pp.136-51, 2011.
DOI : 10.1016/j.addr.2010.04.009

S. Yue, W. Mu, U. Erb, and M. Zöller, The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding, Oncotarget, vol.6, issue.4, pp.2366-84, 2015.
DOI : 10.18632/oncotarget.2958

R. Rossin, S. Van-duijnhoven, T. Läppchen, S. Van-den-bosch, and M. Robillard, -Cyclooctene Tag with Improved Properties for Tumor Pretargeting with the Diels???Alder Reaction, Molecular Pharmaceutics, vol.11, issue.9, pp.3090-3096, 2014.
DOI : 10.1021/mp500275a
URL : https://hal.archives-ouvertes.fr/in2p3-00011243

L. Su, K. Kinzler, B. Vogelstein, A. Preisinger, A. Moser et al., Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene, Science, vol.256, issue.5057, pp.668-70, 1992.
DOI : 10.1126/science.1350108

S. Pan, Y. Wu, S. Cai, Y. Pan, W. Liu et al., Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression, Biochemical and Biophysical Research Communications, vol.458, issue.3, pp.476-82, 2015.
DOI : 10.1016/j.bbrc.2015.01.128

T. Fang, J. Lin, Y. Wang, G. Chen, J. Huang et al., Tetraspanin-8 promotes hepatocellular carcinoma metastasis by increasing ADAM12m expression, Oncotarget, vol.7, issue.26, pp.40630-40643, 2016.
DOI : 10.18632/oncotarget.9769

L. Wei, Y. Li, and Z. Suo, TSPAN8 promotes gastric cancer growth and metastasis via ERK MAPK pathway, Int J Clin Exp Med, vol.8, pp.8599-607, 2015.

N. Kersual, V. Garambois, T. Chardès, J. Pouget, I. Salhi et al., The human M??llerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer, mAbs, vol.49, issue.5, pp.1314-1340, 2014.
DOI : 10.1097/00007691-199103000-00005

W. Bolch, K. Eckerman, G. Sgouros, and S. Thomas, MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature, Journal of Nuclear Medicine, vol.50, issue.3, pp.477-84, 2009.
DOI : 10.2967/jnumed.108.056036

S. Jan, G. Santin, D. Strul, S. Staelens, K. Assié et al., GATE: a simulation toolkit for PET and SPECT, Physics in Medicine and Biology, vol.49, issue.19, pp.4543-61, 2004.
DOI : 10.1088/0031-9155/49/19/007
URL : https://hal.archives-ouvertes.fr/in2p3-00021834